Urinary tract biomaterials.

PURPOSE As a result of endourological advances, biomaterials have become increasingly used within the urinary tract. This review article provides an update on the current status of urinary tract biomaterials, discussing issues of biocompatibility, biomaterials available for use, clinical applications and biomaterial related complications. Perspectives on future materials for use in the urinary tract are also provided. MATERIALS AND METHODS We performed a comprehensive search of the peer reviewed literature on all aspects of biomaterials in the urinary tract using PubMed and MEDLINE. All pertinent articles were reviewed in detail. RESULTS Any potential biomaterial must undergo rigorous physical and biocompatibility testing prior to its commercialization and use in humans. There are currently many different bulk materials and coatings available for the manufacturing of biomaterials, although the ideal material has yet to be discovered. For use in the urinary tract, biomaterials may be formed into devices, including ureteral and urethral stents, urethral catheters and percutaneous nephrostomy tubes. Despite significant advances in basic science research involving biocompatibility issues and biofilm formation, infection and encrustation remain associated with the use of biomaterials in the urinary tract and, therefore, limit their long-term indwelling time. CONCLUSIONS Prosthetic devices formed from biomaterials will continue to be an essential tool in the practicing urologist's armamentarium. Ongoing research is essential to optimize biocompatibility and decrease biomaterial related complications such as infection and encrustation within the urinary tract. Future advances include biodegradables, novel coatings and tissue engineering.

[1]  T. Tammela,et al.  Rabbit muscle and urethral in situ biocompatibility properties of the self-reinforced L-lactide-glycolic acid copolymer 80: 20 spiral stent. , 2002, The Journal of urology.

[2]  Y. Ikada,et al.  In vitro platelet adhesion to nonionic and ionic hydrogels with different water contents. , 1996, Journal of biomedical materials research.

[3]  G. Steinberg,et al.  Novel modification of partial nephrectomy technique using porcine small intestine submucosa. , 2002, Urology.

[4]  J. Lam,et al.  Use of prostatic stents for the treatment of benign prostatic hyperplasia in high-risk patients , 2001, Current urology reports.

[5]  A. Peck,et al.  Molecular cloning, DNA sequence, and gene expression of the oxalyl-coenzyme A decarboxylase gene, oxc, from the bacterium Oxalobacter formigenes , 1994, Journal of bacteriology.

[6]  Ho-Young Song,et al.  Covered, retrievable, expandable urethral nitinol stent: feasibility study in dogs. , 2002, Radiology.

[7]  C. Kalogeropoulou,et al.  Externally Coated Ureteral Metallic Stents: An Unfavorable Clinical Experience , 2002 .

[8]  E. McGuire,et al.  A brief history of urethral catheterization. , 1994, The Journal of urology.

[9]  R. Kulkarni,et al.  Nickel-titanium shape memory alloy Memokath 051 ureteral stent for managing long-term ureteral obstruction: 4-year experience. , 2001, The Journal of urology.

[10]  L. Murphy,et al.  History of Urology , 1933, Annals of Medical History.

[11]  R. Kapoor,et al.  Ureteral reconstruction: small intestine submucosa for the management of strictures and defects of the upper third of the ureter. , 2001, The Journal of urology.

[12]  G. Reid,et al.  Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation. , 2003, Journal of endourology.

[13]  J. Costerton,et al.  The involvement of cell-to-cell signals in the development of a bacterial biofilm. , 1998, Science.

[14]  M. Monga,et al.  Pentosanpolysulfate coating of silicone reduces encrustation. , 2000, Journal of endourology.

[15]  A. Yeung,et al.  Drug‐eluting stents for the prevention of restenosis: In quest for the holy grail , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[16]  G. Reid,et al.  Biomaterials used in urology: current issues of biocompatibility, infection, and encrustation. , 1998, Journal of endourology.

[17]  W. Pauer,et al.  Use of self-expanding permanent endoluminal stents for benign ureteral strictures: mid-term results. , 1999, The Journal of urology.

[18]  M. S. Schepers,et al.  Changing concepts in the aetiology of renal stones , 2000, Current opinion in urology.

[19]  H. Mobley,et al.  Urease-positive bacteriuria and obstruction of long-term urinary catheters , 1987, Journal of clinical microbiology.

[20]  G. Reid,et al.  Examination of bacterial and encrustation deposition on ureteral stents of differing surface properties, after indwelling in humans , 1995 .

[21]  M. Sofer,et al.  Encrustation of biomaterials in the urinary tract , 2000, Current opinion in urology.

[22]  C. Winters,et al.  Proteus mirabilis biofilms and the encrustation of urethral catheters , 2004, Urological Research.

[23]  H. Busscher,et al.  SURFACE-PROPERTIES OF CATHETERS, STENTS AND BACTERIA ASSOCIATED WITH URINARY-TRACT INFECTIONS , 1995 .

[24]  G. Preminger,et al.  Evaluation Of A Dissolvable Ureteral Drainage Stent In A Swine Model , 2002 .

[25]  B. Hekimoğlu,et al.  Urothelial hyperplasia complicating use of metal stents in malignant ureteral obstruction , 2004, European Radiology.

[26]  J. Dimopoulos,et al.  Metal stents: a new treatment of malignant ureteral obstruction. , 1997, The Journal of urology.

[27]  J. Falkinham,et al.  Unique developmental characteristics of the swarm and short cells of Proteus vulgaris and Proteus mirabilis , 1984, Journal of bacteriology.

[28]  Z. Braf,et al.  Intraprostatic metal stents (Prostakath and Urospiral): more than 6 years' clinical experience with 110 patients. , 1996, Journal of endourology.

[29]  F. H. Garrison,et al.  HISTORY OF MEDICINE , 1914 .

[30]  U. Mooppan,et al.  History of urethral catheters and their balloons: drainage, anchorage, dilation, and hemostasis. , 1993, Journal of endourology.

[31]  R. Paterson,et al.  Multilayered small intestinal submucosa is inferior to autologous bowel for laparoscopic bladder augmentation. , 2002, The Journal of urology.

[32]  M. Sofer,et al.  Ureteral segmental replacement using multilayer porcine small-intestinal submucosa. , 2002, Journal of endourology.

[33]  Arthur D. Smith.  Controversies in Endourology , 1995 .

[34]  T. Tammela,et al.  Biocompatibility, encrustation and biodegradation of ofloxacine and silver nitrate coated poly-L-lactic acid stents in rabbit urethra , 2002, Urological Research.

[35]  J. Pope,et al.  Small intestinal submucosa as a urethral coverage layer. , 2001, The Journal of urology.

[36]  Pertti Törmälä,et al.  Interstitial laser coagulation and biodegradable self-expandable, self-reinforced poly-L-lactic and poly-L-glycolic copolymer spiral stent in the treatment of benign prostatic enlargement. , 2002, Journal of endourology.

[37]  C. Fry,et al.  Catheter associated urinary tract infection and encrustation. , 2001, International journal of antimicrobial agents.

[38]  C. Riedl,et al.  Heparin coating reduces encrustation of ureteral stents: a preliminary report. , 2002, International journal of antimicrobial agents.

[39]  F. Adams,et al.  The seven books of Paulus Aegineta , 1844 .

[40]  D. Stickler,et al.  Strategies for the control of catheter encrustation. , 2002, International journal of antimicrobial agents.

[41]  S. Gorman,et al.  Evaluation of a poly(vinyl pyrollidone)-coated biomaterial for urological use. , 2002, Biomaterials.

[42]  R. Holmes,et al.  Direct Quantification of the Enteric BacteriumOxalobacter formigenes in Human Fecal Samples by Quantitative Competitive-Template PCR , 1999, Journal of Clinical Microbiology.

[43]  A. Atala,et al.  Tissue engineered stents created from chondrocytes. , 2001, The Journal of urology.

[44]  J. Richie,et al.  The effects of various indwelling ureteral catheter materials on the normal canine ureter. , 1988, The Journal of urology.

[45]  P. Rotariu,et al.  Reconstruction of rabbit urethra with surgisis small intestinal submucosa. , 2002, Journal of endourology.

[46]  D. T. Graham,et al.  Cellular toxicity of urinary catheters , 1983, The Medical journal of Australia.

[47]  L. P. Wershub.  Urology: From Antiquity to the 20th Century , 1970 .

[48]  James D Watterson,et al.  Use of a temporary ureteral drainage stent after uncomplicated ureteroscopy: results from a phase II clinical trial. , 2003, The Journal of urology.

[49]  G. Reid,et al.  Bacterial biofilms on devices used in nephrology , 1995 .

[50]  S. Wood,et al.  A model to quantify encrustation on ureteric stents, urethral catheters and polymers intended for urological use , 2000, BJU international.

[51]  A. Atala,et al.  In vitro biocompatibility evaluation of naturally derived and synthetic biomaterials using normal human bladder smooth muscle cells. , 2002, The Journal of urology.

[52]  D. Stickler,et al.  Ability of Proteus mirabilis to Swarm over Urethral Catheters , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[53]  A. Manhire,et al.  Metal mesh stents for ureteral obstruction caused by hormone-resistant carcinoma of prostate. , 1999, Journal of endourology.

[54]  G. Pulverer,et al.  Efficacy of silver-coated medical devices. , 1998, The Journal of hospital infection.

[55]  J. Bitschai.  The history of urology in Egypt. , 2012, American journal of surgery.

[56]  B. Liedl,et al.  Catheter-associated urinary tract infections , 2001, Current opinion in urology.

[57]  B. Delahunt,et al.  The assessment of urinary catheter toxicity using cell cultures: validation by comparison with an animal model. , 1986, The Journal of urology.

[58]  Kulkarni,et al.  A new thermo‐expandable shape‐memory nickel‐titanium alloy stent for the management of ureteric strictures , 1999, BJU international.

[59]  H. Mobley,et al.  Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection , 1987, Infection and immunity.

[60]  R. Clayman,et al.  Evaluation of the use of a biodegradable ureteral stent after retrograde endopyelotomy in a porcine model. , 2002, The Journal of urology.

[61]  A. Atala,et al.  In vitro biocompatibility assessment of naturally derived and synthetic biomaterials using normal human urothelial cells. , 2001, Journal of biomedical materials research.

[62]  S. Antimisiaris,et al.  Liposome-coated metal stents: an in vitro evaluation of controlled-release modality in the ureter. , 2000, Journal of endourology.

[63]  H. Mardis,et al.  Ureteral stents. Materials. , 1988, The Urologic clinics of North America.

[64]  H. Mardis,et al.  Comparative evaluation of materials used for internal ureteral stents. , 1993, Journal of endourology.

[65]  H. Busscher,et al.  Importance of surface properties in bacterial adhesion to biomaterials, with particular reference to the urinary tract , 1992 .

[66]  H. Sidhu,et al.  DNA sequencing and expression of the formyl coenzyme A transferase gene, frc, from Oxalobacter formigenes , 1997, Journal of bacteriology.